Evert Homan
10Patents
3h-index
42Co-inventors
56Inventor score
Filing activity: May 24, 2005 → Oct 14, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7253196B2 | Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 | Chemistry; Metallurgy | 10 | Expired |
| US7807700B2 | Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 | Chemistry; Metallurgy | 8 | Active |
| US8541592B2 | Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 | Chemistry; Metallurgy | 3 | Active |
| US8686011B2 | Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 | Chemistry; Metallurgy | 3 | Active |
| US10064869B2 | MTH1 inhibitors for treatment of inflammatory and autoimmune conditions | Emerging Cross-Sectional Technologies | 2 | Active |
| US10632125B2 | MTH1 inhibitors for treatment of inflammatory and autoimmune conditions | Emerging Cross-Sectional Technologies | 1 | Active |
| US9233946B2 | Sulfonamide compounds | Chemistry; Metallurgy | 0 | Active |
| US11504368B2 | 2,6-diamino-3,4-dihydropyrimidin-4-one derivatives and use thereof in therapy | Chemistry; Metallurgy | 0 | Active |
| US10179790B2 | MTH1 inhibitors for treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US12357634B2 | 2,6-diamino-3,4-dihydropyrimidin-4-one derivatives and use thereof in therapy | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.